28 Healthcare Stocks Moving In Thursday's Pre-Market Session

Gainers

• Co-Diagnostics, Inc. CODX stock increased by 25.0% to $15.00 during Thursday's pre-market session. According to the most recent rating by Maxim Group, on March 03, the current rating is at Hold.
• Biocept, Inc. BIOC shares surged 13.8% to $0.64.
• Zosano Pharma, Inc. ZSAN stock moved upwards by 13.6% to $1.00.
• Allied Healthcare Prods, Inc. AHPI stock moved upwards by 12.1% to $18.10.
• Altimmune, Inc. ALT shares increased by 10.5% to $3.15.
• T2 Biosystems, Inc. TTOO stock surged 10.2% to $0.66.
• BioCryst Pharmaceuticals, Inc. BCRX stock increased by 8.6% to $3.81.
• Tonix Pharmaceuticals, Inc. TNXP stock increased by 7.5% to $1.14.
• Beyond Air, Inc. XAIR shares moved upwards by 6.1% to $11.60.
• Novavax, Inc. NVAX stock increased by 6.1% to $12.01. The most recent rating by B. Riley FBR, on February 28, is at Buy, with a price target of $16.00.
• OpGen, Inc. OPGN stock rose 5.9% to $3.40.
• Cocrystal Pharma, Inc. COCP shares increased by 5.8% to $1.27.
• Lianluo Smart, Inc. LLIT shares rose 5.1% to $0.77.
• Aytu BioScience, Inc. AYTU shares moved upwards by 4.9% to $0.62.
• Bionano Genomics, Inc. BNGO shares rose 4.6% to $1.14.
• Inovio Pharmaceuticals, Inc. INO stock increased by 4.0% to $8.35. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.
• Vaxart, Inc. VXRT shares moved upwards by 3.8% to $2.18.
• Trinity Biotech, Inc. TRIB stock surged 3.0% to $1.03.
• Titan Pharmaceuticals, Inc. TTNP stock rose 2.8% to $0.31.

Losers

• Heat Biologics, Inc. HTBX stock plummeted 14.5% to $0.70 during Thursday's pre-market session. The most recent rating by Maxim Group, on February 06, is at Buy, with a price target of $1.00.
• Cellect Biotechnology, Inc. APOP shares plummeted 11.9% to $2.67.
• SINTX Technologies, Inc. SINT shares fell 8.9% to $0.59.
• DBV Technologies, Inc. DBVT stock declined 5.9% to $9.06. The most recent rating by Stifel, on January 09, is at Buy, with a price target of $18.00.
• Intec Pharma, Inc. NTEC stock fell 5.2% to $0.30.
• Canopy Growth, Inc. CGC stock plummeted 4.5% to $16.95. The most recent rating by Stifel Nicolaus, on February 18, is at Buy, with a price target of $35.00.
• OPKO Health, Inc. OPK shares declined 4.2% to $1.59.
• Clovis Oncology, Inc. CLVS stock plummeted 3.4% to $7.90. The most recent rating by B of A Securities, on January 23, is at Neutral, with a price target of $10.00.
• Royal Philips, Inc. PHG stock decreased by 2.8% to $42.76. The most recent rating by Bank of America, on January 13, is at Buy, with a price target of $51.00.